Detalhe da pesquisa
1.
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Cell
; 184(10): 2618-2632.e17, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836156
2.
Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters.
Cell
; 167(5): 1369-1384.e19, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863249
3.
Prioritisation of Candidate Genes Underpinning COVID-19 Host Genetic Traits Based on High-Resolution 3D Chromosomal Topology.
Front Genet
; 12: 745672, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759959
4.
Cohesin-Dependent and -Independent Mechanisms Mediate Chromosomal Contacts between Promoters and Enhancers.
Cell Rep
; 32(3): 107929, 2020 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698000
5.
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.
bioRxiv
; 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299999
6.
Vanishing white matter: deregulated integrated stress response as therapy target.
Ann Clin Transl Neurol
; 6(8): 1407-1422, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402619